Commitments and Contingencies - Additional Information (Detail) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|---|
Jan. 25, 2019 |
Feb. 28, 2021 |
Jan. 31, 2019 |
Mar. 31, 2019 |
Dec. 31, 2018 |
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Commitment And Contingencies [Line Items] | |||||||
Litigation settlement share issued | 500,000 | ||||||
Accrued liability | $ 600,000 | $ 6,237,000 | $ 6,667,000 | ||||
CAO Settlement Agreement | Patent Litigation | |||||||
Commitment And Contingencies [Line Items] | |||||||
Settlement agreement date | January 25, 2019 | ||||||
Number of days litigation settlement to be paid in cash | 5 days | ||||||
Litigation settlement in cash | $ 500,000 | ||||||
Number of days litigation settlement shares to be issued | 30 days | ||||||
Litigation settlement share issued | 500,000 | ||||||
Number of days litigation settlement to be paid in value of stock consideration | 30 days | ||||||
Settlement agreement, terms | The Company agreed (i) to pay to CAO, within five days of the Effective Date, $500,000 in cash, (ii) to issue to CAO, within 30 days of the Effective Date, 500,000 restricted shares of common stock of the Company (the “Stock Consideration”), and (iii) to pay to CAO, within 30 days of December 31, 2021, an amount in cash equal to the difference (if positive) between $1,000,000 and the value of the Stock Consideration on December 31, 2021. | ||||||
Litigation settlement amount in cash equal to difference between value of stock consideration | $ 1,000,000 | ||||||
Contingent loss on patent litigation settlement | $ 1,500,000 | ||||||
Payment for litigation settlement in cash | $ 500,000 | $ 200,000 | |||||
Accrued liability | $ 600,000 | $ 1,000,000.0 |
X | ||||||||||
- Definition Commitment and contingencies. No definition available.
|
X | ||||||||||
- Definition Litigation settlement amount in cash equal to difference between value of stock consideration. No definition available.
|
X | ||||||||||
- Definition Litigation settlement shares issued. No definition available.
|
X | ||||||||||
- Definition Number of days litigation settlement shares to be issued. No definition available.
|
X | ||||||||||
- Definition Number of days litigation settlement to be paid in cash. No definition available.
|
X | ||||||||||
- Definition Number of days litigation settlement to be paid in value of stock consideration. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount awarded to other party in judgment or settlement of litigation. No definition available.
|
X | ||||||||||
- Definition The effective date of a duly executed litigation settlement agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of the terms of a settlement agreement which resolved the legal matter, including the nature of the consideration, timing of payment, and the nature of rights obtained or lost (for example, but not limited to, patent, trademark, copyright, license and franchise rights). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|